Lv4
560 积分 2023-04-11 加入
Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
10天前
已完结
Obinutuzumab Treatment of Follicular Lymphoma
10天前
已完结
[Job exposure matrices]
15天前
已关闭
Occupation and risk of lymphoma: a multicentre prospective cohort study (EPIC)
16天前
已完结
Polygenic Risk, Agent Orange Exposure, and Lymphoid Neoplasms in the Veterans Affairs Million Veteran Program
20天前
已完结
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials
1个月前
已完结
Extranodal Natural Killer T-Cell Lymphoma, Nasal-Type: A Prognostic Model From a Retrospective Multicenter Study
1个月前
已完结
Clinical outcome of patients with follicular lymphoma and bulky disease after Rituximab‐CHOP immunochemotherapy with and without consolidating radiotherapy
1个月前
已完结
First-line LVDP (l-asparaginase, etoposide, dexamethasone, and cisplatin) regimen combined with radiotherapy is effective for early-stage extranodal natural killer/T-cell lymphoma, nasal type
2个月前
已完结
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis
2个月前
已完结
皖公网安备34019202002308
